Company
APT Medical, Inc.
Headquarters: Shenzhen, China
Employees: 1,511
Market Cap
CN¥21.67 Billion
CNY as of Jan. 1, 2023
US$3.14 Billion
APT Medical, Inc. Categories
China
languages
Healthcare
languages
Medical Devices
China Healthcare
China Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
Abbott
|
$191.43 B |
Medtronic
|
$103.38 B |
|
Stryker Corporation
|
$92.52 B |
|
Boston Scientific Corporation
|
$65.90 B |
|
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
|
$56.23 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.
Stocks & Indices
APT Medical, Inc. has the following listings and related stock indices.
Stock: SSE: 688617